WHAT'S NEW

"The Canadian DME Summit convened a fantastic group of multidisciplinary stakeholders. Get key outcomes & learn more: http://t.co/vPDcTn8g4Y - 19 hours ago via Twitter
"VEGF-targeted drugs are breaking barriers to care for many patients who suffer from DME. Recognizing the life-changing implications of these therapies, the Angiogenesis Foundation convened the Canadian National Multistakeholder Expert Summit for Diabetic Macular Edema (DME), bringing together diverse groups of regional representatives ranging from retinal specialists and diabetologists to advocates, researchers, and patients. Participants discussed the current state of the field and addressed barriers to optimized care for DME. Learn about key outcomes here: - 1 day ago via Facebook
Diabetes is the leading cause of blindness among adults aged 20-74. Patients with type 1 or type 2 diabetes are at risk for developing diabetic retino Read More >
"1 year ago we launched the Do it Yourself Health Revolution at the World Economic Forum. We now have members from all over the world! DiY Health empowers users with information on lifestyles that keep us healthy and *prevent* getting sick in the first place. Join the movement & get weekly health-saving tips: www.diyhealth.org. #OwnYourHealth - 2 days ago via Facebook
"1 year ago we launched @DIYhealthrev- join the movement & get weekly health-saving tips: http://t.co/Uvfk8BtafJ #OwnYourHealth - 2 days ago via Twitter
"What year did the first clinical trial of an antiangiogenic drug begin in cancer patients? Find the answer here! http://t.co/ymMJAkpV6C - 6 days ago via Twitter
"Highlights from 2014: Antiangiogenic agent ramucirumab is the first treatment to be FDA approved for advanced stomach cancer that has not responded to chemotherapy. - 6 days ago via Facebook
"Did you know-- The Angiogenesis Foundation was founded in 1994 to improve global health by facilitating the development and application of angiogenesis-based medicines, diets, and lifestyles. What have we done since then? See the progress over the past 20 years: https://www.youtube.com/watch?v=G-B0sa9ZBBI - 7 days ago via Facebook
"Antiangiogenic agent ramucirumab is the 1st treatment for advanced stomach cancer that's non-responsive to chemo: http://t.co/zbvOTnqKit - 1 week ago via Twitter
"A new book chapter, co-authored by Dr. William Li, explains how tissue from the placenta can treat chronic wounds: http://t.co/O88oVSTApL - 2 weeks ago via Twitter
"Chronic wounds affect as many as 1 – 2% of people in their lifetime. But there’s good news: recent developments in understanding how a reproductive tissue in the placenta could be used as a treatment method offers patients new hope for effective treatment. Learn more in a recent book chapter co-authored by Dr. William Li, President of the Angiogenesis Foundation: “The Use of Human Amion/Chorion Membrane in the Clinical Setting for Lower Extremity Repair: A Review.” - 2 weeks ago via Facebook
"Human amniotic membrane is a reproductive tissue in the placenta- Can you guess how it can help people w/ diabetes? http://t.co/NW3ZBayiBK - 2 weeks ago via Twitter
For someone with diabetes, a stubbed toe, trivial scrape, or minor cut can rapidly become serious. This condition impairs the body’s healing ability Read More >
"What is the common denominator in over 70 diseases? ow.ly/GQ1Xl - 2 weeks ago via Facebook
"In the healthy body, a series of biologic "on" and "off” switches help modulate angiogenesis. Learn more: http://t.co/thMW8NmWoJ - 2 weeks ago via Twitter
"Good news! Antiangiogenic Agent Ramucirumab Gets FDA Approval for Treating Non-Small Cell Lung Cancer: http://t.co/IsEqYnmaUk - 2 weeks ago via Twitter
"More progress with antiangiogenic agent Ramucirumab! - 2 weeks ago via Facebook
The US Food and Drug Administration (FDA) expanded the indication of ramucirumab (Cyramza, Eli Lilly) to include the treatment of metastatic non-small Read More >
"Good news! Anti-VEGF Agent Ranibizumab Gets FDA Breakthrough Therapy Designation for Diabetic Retinopathy. If approved, this would be the first ocular medication for the treatment of diabetic retinopathy: - 3 weeks ago via Facebook
The US Food and Drug Administration (FDA) has granted Lucentis (ranibizumab), a vascular endothelial growth factor (VEGF) inhibitor, its Breakthrough Read More >
"What is the common denominator in over 70 diseases? http://t.co/6BmqhNx97v - 3 weeks ago via Twitter
"Angiogenesis treatment can benefit patients with many life-threatening diseases- view our publications to learn more: - 3 weeks ago via Facebook
"Blood vessels consist of endothelial cells, which cover a total surface area of 1000m2 in an adult-- roughly the size of a tennis court! - 3 weeks ago via Twitter
"Did you know? Our veins contain 65% of the body's total blood supply at any given moment! - 3 weeks ago via Facebook
"Restoring the body’s natural control of angiogenesis, new blood vessel growth, is a new approach to fighting disease. Learn more: - 3 weeks ago via Facebook
Health Canada recently approved anti-VEGF agent alibercept (Eylea) for the treatment of diabetic macular edema (DME). Eylea is also approved in Canada Read More >
The U.S. Food and Drug Administration (FDA) has accepted for priority review the supplemental biologics license application (sBLA) for EYLEA® (afli Read More >
In the National Institutes of Health (NIH) sponsored, Diabetic Retinopathy Clinical Research Network (DRCR.net) comparative effectiveness study in pat Read More >
The U.S. Food and Drug Administration (FDA) approved antiangiogenic agent bevacizumab (Avastin®) in combination with chemotherapy for the treatment o Read More >
On October 14, the Angiogenesis Foundation hosted a Patient Forum and Dinner, "Antiangiogenesis: Answer to Cancer," at the Westin Boston Waterfront Ho Read More >
The U.S. Food and Drug Administration (FDA) has approved EYLEA® (aflibercept) Injection for the treatment of Macular Edema following Retinal Vein Occ Read More >
Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd. has received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for Read More >

ANGIO LIFE

Dr. Li shares 22 Cancer Fighting Tips with Dr. Oz

Dr. William Li joins Dr. Oz to share 22 ways to cut your risk of cancer risk by 50 percent. Read More >

Dr. William Li presents at TED

Dr. William Li presents “Can we eat to starve cancer?” at TED 2010 in Long Beach, CA. Read More >

 

IN THE MEDIA

4744.Reuters-Logo

November 6, 2014: For the second consecutive year, the Angiogenesis Foundation has received the highest rating from Charity Navigator, the prominent independent evaluator of charities. Read More >

DoctorOZ-1

May 20, 2014: “The Dr. Oz Show” features Dr. William Li who shares 3 all-natural breakthroughs that can reduce your risk of cancer. Read More >

marketwatch-logo

April 23, 2014: The Bates-Jensen Wound Reach Foundation and the Angiogenesis Foundation announce Keith Brantly will run in the Wound Reach Foundation OUCH! Race. Read More >

DoctorOZ (1)

February 7, 2014: Dr. William Li appears on “The Dr. Oz Show” to share 22 ways to cut your cancer risk by 50%. Read More >

yahoo-news-logo

January 21, 2014: The Angiogenesis Foundation, in collaboration with musician / activist Peter Gabriel, has launched the Do iT Yourself Health Revolution Read More >

yahoo-news-logo

November 7, 2013: The Angiogenesis Foundation receives highest rating from Charity Navigator, a premiere charity evaluator, for good governance, fiscal management, accountability and transparency. Read More >

marketwatch-logo

September 26, 2013: The Angiogenesis Foundation Launches Multimedia Campaigns for Saving Vision at the 13th Euretina Congress Read More >

bostoncomlogo

September 26, 2013: The Angiogenesis Foundation Releases International White Paper on Improving Outcomes in the Treatment and Management of Metastatic Colorectal Cancer at the European Cancer Congress 2013 Read More >

marketwatch-logo

September 26, 2013: The Angiogenesis Foundation Releases International White Paper on Advancing Treatment of Wet Age-Related Macular Degeneration at the 13th Euretina Congress Read More >

WSJ-Logo2

July 16, 2013: The Angiogenesis Foundation Presents Concept of Antiangiogenic Foods at IFT 2013 Annual Meeting + Food Expo Read More >

usatoday_logo

June 4, 2013: Dr. William Li discusses the impact of drug shortages for cancer patients in USA Today. Read More >

usatoday_logo

June 3, 2013: Dr. William Li discusses recent developments for patients with metastatic thyroid cancer in USA Today. Read More >

WSJ-Logo2

May 31, 2013: The Angiogenesis Foundation releases Advancing Critical Pathways Forward in the Treatment of Colorectal and Kidney Cancer – White Papers at the ASCO Annual Meeting 2013. Read More >

WSJ-Logo2

May 30, 2013: The Angiogenesis Foundation Launches Science of Colorectal Cancer Patient Resource at ASCO Annual Meeting 2013. Read More >

WSJ-Logo2

May 7, 2013: The Angiogenesis Foundation releases white paper, “Critical Pathways Forward for Wet Age-Related Macular Degeneration in Asia Pacific.” Read More >

HEAR FROM THE EXPERTS

   

The “Best of Antiangiogenesis” is a series of webcasts, generated through Project ENABLE™, featuring presentations from leading medical experts describing research and perspectives on new angiogenesis-based therapies.

To view additional webcasts, click here
 

LEARN ABOUT DISEASE TREATMENTS

PUBLICATIONS

GREEN TEA

Our tea research is part of our Eat to Beat Cancer initiative, which is setting out to find foods and beverages that restore balance to the body's angiogenesis system. By purchasing this tea you are supporting our research and helping to advance the frontiers of cancer prevention.